首页|乌司他丁联合重酒石酸去甲肾上腺素治疗脓毒症休克的疗效及对肝肾功能的影响

乌司他丁联合重酒石酸去甲肾上腺素治疗脓毒症休克的疗效及对肝肾功能的影响

扫码查看
目的 探究乌司他丁(UTI)联合重酒石酸去甲肾上腺素治疗脓毒症休克的效果及对肝肾功能的影响.方法 回顾性选取2021年1月至2024年1月安庆市立医院收治的54例脓毒症休克患者的临床资料,依据治疗方案不同分为对照组(n=25)和联合治疗组(n=29),对照组给予重酒石酸去甲肾上腺素治疗,联合治疗组在对照组基础上加予UTI注射治疗,治疗1周后比较两组治疗效果、治疗24 h内心率(HR)、平均动脉压(MAP)、治疗前后炎症指标[C反应蛋白(CRP)、白细胞介素 1β(IL-1β)和肿瘤坏死因子α(TNF-α)]、肝功能指标[血清总胆红素(TBil)、γ-谷氨酰转肽酶(γ-GT)和天门冬氨酸氨基转移酶(AST)]和肾功能指标[血尿素氮(BUN)、血清肌酐(Scr)和尿酸(UA)]水平,统计两组预后情况.结果 联合治疗组治疗总有效率高于对照组,差异有统计学意义(P<0.05);随着治疗时间增加,两组HR逐渐降低,MAP逐渐升高,且联合治疗组HR低于对照组,MAP高于对照组,差异有统计学意义(P<0.05);治疗后,两组炎症指标(CRP、IL-1β和TNF-α)、肝功能指标(TBil、γ-GT和AST)和肾功能指标(BUN、Scr和UA)水平较治疗前降低,且联合治疗组低于对照组,差异有统计学意义(P<0.05);两组治疗期间不良反应发生情况比较差异无统计学意义(P>0.05),联合治疗组28 d死亡率低于对照组,差异有统计学意义(P<0.05).结论 UTI联合重酒石酸去甲肾上腺素用于脓毒症休克治疗效果显著,可改善患者肝肾功能,降低炎症水平,不良反应少.
Efficacy of ulinastatin combined with norepinephrine bitartrate on septic shock and its in-fluence on liver-kidney function
Objective To explore the effect of ulinastatin(UTI)combined with norepinephrine bitartrate in the treatment of septic shock and its influence on liver-kidney function.Methods The clinical data of 54 patients with septic shock at Anqing Municipal Hospital from January 2021 to January 2024 were ret-rospectively analyzed.The patients were divided into a control group(n=25)and a combined treatment group(n=29)based on different treatment regimens.All patients received basic treatments including fluid resuscita-tion,electrolyte regulation,antibacterial therapy,respiratory support and nutritional support.In addition to the basic treatments,the control group received norepinephrine bitartrate,while the combined treatment group was treated with UTI injection in addition to norepinephrine bitartrate.The therapeutic effect after 1 week of treat-ment,changes in heart rate(HR)and mean arterial pressure(MAP)within 24 hours of treatment and changes in inflammatory marks[C-reactive protein(CRP),interleukin-1β(IL-1β),tumor necrosis factor(TNF)],liver function indicators[serum total bilirubin(TBil),γ-glutamyl transpeptidase(γ-GT)and aspartate amino-transferase(AST)]and renal function indicators[blood urea nitrogen(BUN),serum creatinine(Scr)and uri-nary acid(UA)]before and after treatment were compared between both groups.The prognosis of the two groups was statistically analyzed.Results The total effective rate of treatment in the combined treatment group was significantly higher than that in the control group,and the difference was statistically significant(P<0.05).As the treatment time increased,HR in both groups decreased gradually while MAP increased gradually.The HR in the combined treatment group was lower than that in the control group,and the MAP was higher than that in the control group,and the difference was statistically significant(P<0.05).After treat-ment,the levels of inflammatory markers(CRP,IL-1β and TNF),liver function indicators(TBil,γ-GT and AST)and renal function indicators(BUN,Scr and UA)were significantly reduced in both groups.The levels in the combined treatment group were lower than those in the control group,and the difference was statistically significant(P<0.05).There were no significant differences in adverse reactions between the two groups(P>0.05).The 28-day mortality rate in the combined treatment group was significantly lower compared to the con-trol group,and the difference was statistically significant(P<0.05).Conclusion The combination of UTI and norepinephrine bitartrate is effective in treating septic shock.This treatment can improve liver and kidney function,reduce inflammation levels,and has few adverse reactions.

Septic shockUlinastatinNorepinephrine bitartrateTreatment effect

吕小巍、李晓倩、白兆青

展开 >

安庆市立医院急诊科,安徽,安庆 246000

脓毒症休克 乌司他丁 重酒石酸去甲肾上腺素 治疗效果

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(12)